APA (7th ed.) Citation

V, L., FC, M., DC, T., C, S., R, K., J, L., . . . SA, B. (2025). Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach. CNS drugs, 39(3), 305. https://doi.org/10.1007/s40263-024-01153-5

Chicago Style (17th ed.) Citation

V, Li, et al. "Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach." CNS Drugs 39, no. 3 (2025): 305. https://doi.org/10.1007/s40263-024-01153-5.

MLA (9th ed.) Citation

V, Li, et al. "Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach." CNS Drugs, vol. 39, no. 3, 2025, p. 305, https://doi.org/10.1007/s40263-024-01153-5.